vTv Therapeutics (VTVT) Change in Receivables (2014 - 2024)

vTv Therapeutics has disclosed Change in Receivables across 10 years of filings, most recently posting -$180000.0 for Q4 2024.

• In Q4 2024, Change in Receivables fell 276.47% year-over-year to -$180000.0; the TTM figure through Dec 2024 stood at -$40000.0 (up 43.66% YoY), while the FY2024 annual figure was -$40000.0, up 43.66% from the prior year.
• Change in Receivables came in at -$180000.0 for Q4 2024 at vTv Therapeutics, down from -$64000.0 in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $928000.0 in Q3 2021 to a low of -$871000.0 in Q4 2021.
• Average Change in Receivables over 5 years is $4133.3, with a median of -$2000.0 recorded in 2021.
• The largest YoY upside for Change in Receivables was 6528.57% in 2021 against a maximum downside of 704.86% in 2021.
• Over 5 years, Change in Receivables stood at $144000.0 in 2020, then slumped by 704.86% to -$871000.0 in 2021, then soared by 113.32% to $116000.0 in 2022, then decreased by 12.07% to $102000.0 in 2023, then sank by 276.47% to -$180000.0 in 2024.
• Per Business Quant data, the three most recent Change in Receivables figures were -$180000.0 in Q4 2024, -$64000.0 in Q3 2024, and -$675000.0 in Q2 2024.